These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 33129718

  • 1. Resetting the Bar of Castration Resistance - Understanding Androgen Dynamics in Therapy Resistance and Treatment Choice in Prostate Cancer.
    Shore ND, Morgans AK, Ryan CJ.
    Clin Genitourin Cancer; 2021 Jun; 19(3):199-207. PubMed ID: 33129718
    [Abstract] [Full Text] [Related]

  • 2. Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.
    Cheng Q, Butler W, Zhou Y, Zhang H, Tang L, Perkinson K, Chen X, Jiang XS, McCall SJ, Inman BA, Huang J.
    Eur Urol; 2022 May; 81(5):446-455. PubMed ID: 35058087
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA, Yen AE, Weigel NL.
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [Abstract] [Full Text] [Related]

  • 4. Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy.
    Beck J, Rouleau M, Lemire F, Neveu B, Déry M, Thériault B, Dubois G, Guérette D, Pouliot F.
    Prostate; 2023 May; 83(7):670-677. PubMed ID: 36851864
    [Abstract] [Full Text] [Related]

  • 5. Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further.
    Fujimoto N.
    J UOEH; 2016 Jun 01; 38(2):129-38. PubMed ID: 27302726
    [Abstract] [Full Text] [Related]

  • 6. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.
    Actas Urol Esp; 2011 Jun 01; 35(10):565-79. PubMed ID: 21757258
    [Abstract] [Full Text] [Related]

  • 7. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations.
    Crawford ED, Heidenreich A, Lawrentschuk N, Tombal B, Pompeo ACL, Mendoza-Valdes A, Miller K, Debruyne FMJ, Klotz L.
    Prostate Cancer Prostatic Dis; 2019 Mar 01; 22(1):24-38. PubMed ID: 30131604
    [Abstract] [Full Text] [Related]

  • 8. New agents and strategies for the hormonal treatment of castration-resistant prostate cancer.
    Sharifi N.
    Expert Opin Investig Drugs; 2010 Jul 01; 19(7):837-46. PubMed ID: 20524793
    [Abstract] [Full Text] [Related]

  • 9. Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC).
    Li Y, Shi H, Zhao Z, Xu M.
    BMC Urol; 2022 Oct 18; 22(1):162. PubMed ID: 36258196
    [Abstract] [Full Text] [Related]

  • 10. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.
    Karantanos T, Corn PG, Thompson TC.
    Oncogene; 2013 Dec 05; 32(49):5501-11. PubMed ID: 23752182
    [Abstract] [Full Text] [Related]

  • 11. Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation.
    Thelen P, Heinrich E, Bremmer F, Trojan L, Strauss A.
    Prostate; 2013 Nov 05; 73(15):1699-709. PubMed ID: 23868789
    [Abstract] [Full Text] [Related]

  • 12. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
    Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME, Nelson CC.
    Cancer Res; 2008 Aug 01; 68(15):6407-15. PubMed ID: 18676866
    [Abstract] [Full Text] [Related]

  • 13. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.
    Begemann D, Wang Y, Yang W, Kyprianou N.
    Prostate; 2020 Sep 01; 80(12):926-937. PubMed ID: 32542812
    [Abstract] [Full Text] [Related]

  • 14. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
    O'Reilly D, Downing T, Kouba S, Potier-Cartereau M, McKenna DJ, Vandier C, Buchanan PJ.
    Cell Calcium; 2022 May 01; 103():102554. PubMed ID: 35193095
    [Abstract] [Full Text] [Related]

  • 15. [COST ANALYSIS OF ANDROGEN DEPRIVATION THERAPY AND DRUGS FOR CASTRATION-RESISTANT PROSTATE CANCER].
    Nishizawa K, Hattahara K, Onishi H, Yoshida T.
    Nihon Hinyokika Gakkai Zasshi; 2021 May 01; 112(2):53-57. PubMed ID: 35444081
    [Abstract] [Full Text] [Related]

  • 16. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH, Ku JY, Ha JM, Bae SS, Lee JZ, Kim CS, Ha HK.
    Prostate; 2017 Jan 01; 77(1):60-71. PubMed ID: 27550197
    [Abstract] [Full Text] [Related]

  • 17. [Mechanisms of drug resistance in endocrinotherapy for castration-resistant prostate cancer].
    Bo B, Guo JB, Liu LR, Wei Q.
    Zhonghua Nan Ke Xue; 2021 Feb 01; 27(2):167-171. PubMed ID: 34914335
    [Abstract] [Full Text] [Related]

  • 18. Platelet-Synthesized Testosterone in Men with Prostate Cancer Induces Androgen Receptor Signaling.
    Zaslavsky AB, Gloeckner-Kalousek A, Adams M, Putluri N, Venghatakrishnan H, Li H, Morgan TM, Feng FY, Tewari M, Sreekumar A, Palapattu GS.
    Neoplasia; 2015 Jun 01; 17(6):490-6. PubMed ID: 26152357
    [Abstract] [Full Text] [Related]

  • 19. Restoration of the cellular secretory milieu overrides androgen dependence of in vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor.
    Patki M, Huang Y, Ratnam M.
    Biochem Biophys Res Commun; 2016 Jul 22; 476(2):69-74. PubMed ID: 27179779
    [Abstract] [Full Text] [Related]

  • 20. New therapies for castration-resistant prostate cancer: efficacy and safety.
    Beltran H, Beer TM, Carducci MA, de Bono J, Gleave M, Hussain M, Kelly WK, Saad F, Sternberg C, Tagawa ST, Tannock IF.
    Eur Urol; 2011 Aug 22; 60(2):279-90. PubMed ID: 21592649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.